Repros Therapeutics (RPRX) Misses Q2 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Repros Therapeutics Inc.(R) Reports Second Quarter 2015 Financial Results
August 10, 2015 9:15 AM EDTTHE WOODLANDS, Texas, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq: RPRX) today announced financial results for the second quarter ended June 30, 2015.
Financial Results
Net loss for the three month period ended June 30, 2015, was ($7.8) million or ($0.32) per share as compared to a net loss of ($8.7) million or ($0.38) per share for the same period in 2014. The net loss for the six month period ended June 30, 2015, was ($16.3) million or ($0.67) per share as compared to a net loss of ($17.5) million or ($0.76) per share for the same period in 2014. The decreases were primarily due to... More
Repros Therapeutics Inc.(R) Reports Second Quarter 2015 Financial Results
August 10, 2015 9:15 AM EDTTHE WOODLANDS, Texas, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq: RPRX) today announced financial results for the second quarter ended June 30, 2015.
Financial Results
Net loss for the three month period ended June 30, 2015, was ($7.8) million or ($0.32) per share as compared to a net loss of ($8.7) million or ($0.38) per share for the same period in 2014. The net loss for the six month period ended June 30, 2015, was ($16.3) million or ($0.67) per share as compared to a net loss of ($17.5) million or ($0.76) per share for the same period in 2014. The decreases were primarily due to... More
